In silico modeling of the specific inhibitory potential of thiophene-2,3-dihydro-1,5-benzothiazepine against BChE in the formation of β-amyloid plaques associated with Alzheimer's disease

Theoretical Biology and Medical Modelling

Volumn 7, Issue 1, 2010, Pages

  Ul Haq, Zaheer ^a   Khan, Waqasuddin ^a   Kalsoom, Saima ^b   Ansari, Farzana L ^b  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b QUAID I AZAM UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

(E) 3 (2 (THIOPHENE 2 YL) 2,3 DIHYDROBENZO(B)(1,4)THIAZEPIN 4 YL)PHENOL; (E)-3-(2-(THIOPHENE-2-YL)-2,3-DIHYDROBENZO(B)(1,4)THIAZEPIN-4-YL)PHENOL; AMYLOID; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; THIAZEPINE DERIVATIVE;

ALGORITHM; ALZHEIMER DISEASE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; MOLECULAR DYNAMICS; PATHOLOGY; THERMODYNAMICS;

ALGORITHMS; ALZHEIMER DISEASE; AMYLOID; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; HUMANS; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; MOLECULAR STRUCTURE; THERMODYNAMICS; THIAZEPINES;

EID: 77953500278     PISSN: None     EISSN: 17424682     Source Type: Journal    
DOI: 10.1186/1742-4682-7-22     Document Type: Article

References (51)

1. The Alzheimer's disease index. http://www.medicinenet.com/alzheimers- disease/article.htm
2. The cholinergic hypothesis - Ten years on. EK Perry, Br Med Bull 1986 42 63 69 3513895
3. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development. AV Terry JJ Buccafusco, J Pharmacol Exp Ther 2003 306 821 828 10.1124/jpet.102.041616 12805474
4. Butyrlcholinesterase: Its structure and function. Ezio Giacobini, Taylor and Francis Group plc 2003
5. Neurological cholinesterases in normal brain and in Alzheimer's disease: relationship to plaques, tangles and patterns of selective vulnerability. CI Wright C Geula MM Mesulam, Ann Neurol 1993 34 373 384 10.1002/ana.410340312 8363355
6. Recent approaches to novel anti-Alzheimertherapy. MC Carreiras JL Marco, Curr Pharm Design 2004 25 3167 3175
7. Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk. O Combarros JA Riancho J Infante C Sãudo J Llorca MT Zarrabeitia J Berciano, Dement Geriatr Cogn Disord 2005 20 153 157 10.1159/000087065 16020944 (Pubitemid 41191631)
8. Protease inhibitors and indolamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer's disease. CI Wright C Geula MM Mesulam, Ann N Y Acad Sci 1993 695 65 68 10.1111/j.1749-6632.1993.tb23029.x 8239315 (Pubitemid 23348238)
9. Non-classical actions of cholinesterases: Role in cellular differentiation, tumorigenesis and Alzheimer's disease. DH Small S Michaelson G Sberna, Neurochem Int 1996 28 453 483 10.1016/0197-0186(95)00099-2 8792327
10. Butyrylcholinesterase attenuates amyloid fibril formation in vitro. S Diamant E Podoly A Friedler H Ligumsky O Livnah H Soreq, Proc Natl Acad Sci 2006 103 8628 8633 10.1073/pnas.0602922103 16731619
11. The oxidation products of melatonin derivatives exhibit acetylcholinesterase and butyrylcholinesterase inhibitory activity. A Siwicka Z Moleda K Wojtasiewicz A Zawadzka JK Maurin M Panasiewicz T Pacuszka Z Czarnocki, J Pineal Res 2008 45 40 49 10.1111/j.1600-079X.2008.00554.x 18284552
12. A tomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. JL Sussman M Harel F Farlow C Oefner A Goldman L Toker I Silman, Science 1991 253 872 879 10.1126/science.1678899 1678899
13. Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity. DC Vellom Z Radic Y Li NA Pickering S Camp P Taylor, Biochemistry 1993 32 12 17 10.1021/bi00052a003 8418833
14. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease. Q Yu HW Holloway T Utsuki A Brossi, J Med Chem 1999 42 1855 1861 10.1021/jm980459s 10346939
15. Acetyl and butyrylcholinesterase-inhibiting triterpenoid alkaloids from Buxus papillosa. S Parveen A Khalid A Farooq MI Choudhary, Phytochemistry 2001 58 963 968 10.1016/S0031-9422(01)00332-6 11684196
16. New cholinesterase-inhibiting steroidal alkaloids from Sarcococca saligna. F Feroz A Khalid SA Nawaz MR Khan MI Choudhary, Helvetica Chimica Acta 2004 87 439 448 10.1002/hlca.200490042 (Pubitemid 38461750)
17. New pregnane-type steroidal alkaloids from Sarcococca saligna and their cholinesterase inhibitory activity. Atta-ur-Rahman F Feroz I Naeem Zaheer-ul-Haq SA Nawaz Naeema Khan MR Khan MI Choudhary, Steroids 2004 69 735 741 15685740
18. Cholinesterase inhibitory pregnane-type steroidal alkaloids from Sarcococca hookeriana. MI Choudhary KP Devkota SA Nawaz R Ranjit Atta-ur-Rahman, Steroids 2005 70 295 303 10.1016/j.steroids.2004.11.007 15784284
19. Molecular docking studies of natural cholinesterase-inhibiting steroidal alkaloids from Sarcococca saligna. Zaheer-ul-Haq B Wellenzohn KR Liedl BM Rode, J Med Chem 2003 46 5087 5090 10.1021/jm0309194 14584959 (Pubitemid 37352046)
20. 3D-QSAR Studies on natural acetylcholinesterase inhibitors of Sarcococca saligna by comparative molecular field analysis (CoMFA). Zaheer-ul-Haq B Wellenzohn S Tonmunphean A Khalid MI Choudhary BM Rode, Bio Med Chem Lttrs 2003 13 4375 4380 10.1016/j.bmcl.2003.09.034 (Pubitemid 37490821)
21. Juliflorine: A potent natural peripheral anionic-site-binding inhibitor of acetylcholinesterase with calcium-channel blocking potential, a leading candidate for Alzheimer's disease therapy. Zaheer-ul-Haq B Wellenzohn KR Liedl BM Rode, Biochem Biophys Res Comm 2005 332 1171 1179 10.1016/j.bbrc.2005.05.068 16021692
22. Withanolides, a new class of natural cholinesterase inhibitors with calcium antagonistic properties. MI Choudhary SA Nawaz Zaheer-ul-Haq MA Lodhi MN Ghayur S Jalil Riaz Naheed S Yousuf Malik Abdul AH Gilani Atta-ur-Rahman, Biochem Biophys Res Comm 2005 334 276 287 10.1016/j.bbrc.2005.06.086 16108094
23. Cholinesterase inhibitory and spasmolytic potential of steroidal alkaloids. A Khalid Zaheer-ul-Haq MN Ghayur F Feroz Atta-ur-Rahman AH Gilani MI Choudhary, J Steroid Biochem Mol Biol 2004 92 477 484 10.1016/j.jsbmb.2004.08. 003 15795993
24. Structural insight into the inhibition of acetylcholinesterase by 2,3,4, 5-tetrahydro-1, 5-benzothiazepines. SA Nawaz S Umbreen A Kahlid FL Ansari Atta-Ur-Rahman MI Choudhary, J Enz Inh Med Chem 2008 23 206 212 10.1080/14756360701533080 (Pubitemid 351404839)
25. 1, 5-Benzothiazepine, a versatile pharmacophore: A review. JB Bariwal KD Upadhyay AT Manvar JC Trivedi JS Singh KS Jain AK Shah, Eur J Med Chem 2008 43 2279 2290 10.1016/j.ejmech.2008.05.035 18639369
26. Syntheses and biological activities of chalcone and 1, 5-benzothiazepine derivatives: Promising new free-radical scavengers, and esterase, urease, and -glucosidase inhibitors. FL Ansari S Umbreen L Hussain T Makhmoor SA Nawaz MA Lodhi SN Khan F Shaheen MI Choudhary, Chem Biodiv 2005 2 487 496 10.1002/cbdv.200590029 (Pubitemid 40691591)
27. Solid-phase synthesis and biological evaluation of a parallel library of 2,3-dihydro-1, 5-benzothiazepines. FL Ansari F Iftikhar B Mirza M Baseer U Rasheed, Bioorg Med Chem 2008 16 7691 7697 10.1016/j.bmc.2008.07.009 18650096
28. SYBYL molecular modeling software, St. Louis MO Tripos Associated Ltd
29. A rapidly convergent descent method for minimization. MJD Fletcher R Powell, Comp J 1963 6 163 168
30. The tripos force field. M Clark RD Cramer N Van Obdenbosch, J Comput Chem 1989 10 982 1012 10.1002/jcc.540100804
31. Iterative partial equalization of orbital electronegativity - A rapid access to atomic charges. J Gasteiger M Marsili, Tetrahedron 1980 36 3219 3228 10.1016/0040-4020(80)80168-2
32. Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. M Harel I Schalk L Ehret-Sabatier F Bouet M Goeldner C Hirth PH Axelsen I Silman, Proc Natl Acad Sci 1993 90 9031 9035 10.1073/pnas.90.19.9031 8415649
33. Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. Y Nicolet O Lockridge P Masson JC Fontecilla-Camps F Nachon, J Biol Chem 2003 278 41141 41147 10.1074/jbc.M210241200 12869558
34. The Protein Data Bank: A historical perspective. HM Berman, Acta Cryst 2008 64 88 95 10.1107/S0108767307035623
35. MolDock: A new technique for high-accuracy docking. R Thomsen MH Christensen, J Med Chem 2006 49 3315 3321 10.1021/jm051197e 16722650
36. Differential evolution - A simple and efficient adaptive scheme for global optimization over continuous spaces; Technical report. R Storn K Price, International Computer Science Institute: Berkley, CA 1995
37. Docking conformationally flexible small molecules into a protein binding site through evolutionary programming. DK Gehlhaar G Verkhivker PA Rejto DB Fogel LJ Fogel ST Freer, Proceedings of the Fourth International Conference on Evolutionary Programming: 1-3 March 1995; San Diego MIT Press, John R McDonnell, Robert G Reynolds, David B Fogel, 1995 615 627
38. Fully automated and rapid flexible docking of inhibitors covalently bound to serine proteases. DK Gehlhaar D Bouzida PA Rejto Eds, Proceedings of the Seventh International Conference on Evolutionary Programming: 25-27 March 1998; San Diego Springer, William Porto V, Saravanan N, Donald E Waagen, Eiben AE, 1998 449 461
39. GEMDOCK: A generic evolutionary method for molecular docking. JM Yang CC Chen, Proteins 2004 55 288 304 10.1002/prot.20035 15048822
40. Z Michalewicz, Genetic Algorithms + Data Stuctures = Evolution Programs Spinger-Verlag: University of North Carolina 1996
41. Z Michalewiez DB Fogel, How to Solve It: Modern Heuristics Spinger-Verlag: University of North Carolina 2000
42. A simplex method for function minimization. JA Nelder R Mead, Comp J 1965 7 308 313
43. AMBER molecular dynamics package. http://www.ambermd.org
44. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. JP Ryckaert G Ciccotti HJC Berendsen, J Comput Phys 1977 23 327 341 10.1016/0021-9991(77)90098-5
45. Molecular dynamics with coupling to an external bath. HJC Berendsen JPM Postma WF van Gunsteren A DiNola JR Haak, J Chem Phys 1984 81 3684 3690 10.1063/1.448118
46. A smooth particle mesh Ewald method. U Essmann L Perera T Berkowitz ML Darden, J Chem Phys 1995 103 8577 8593 10.1063/1.470117
47. VMD - Visual molecular dynamics. W Humphrey A Dalke K Schulten, J Mol Graph Model 1996 14 33 38 10.1016/0263-7855(96)00018-5 (Pubitemid 26152973)
48. Accurate prediction of the bound conformation of galanthamine in the active site of Torpedo californica acetylcholinesterase using molecular docking. C Pilger C. Bartolucci D Lamba A Tropsha G Fels, J Mol Graph Model 2001 19 288 296 10.1016/S1093-3263(00)00056-5 11449566
49. Structure and dynamics of the active site gorge of acetylcholinesterase: Synergistic use of molecular dynamics simulation and X-ray crystallography. PH Axelsen M Harel I Silman JL Sussman, Protein Sci 1994 3 188 197 8003956
50. Molecular interactions of cholinesterases inhibitors using in silico methods: Currents status and future prospects. MTH Khan, New Biotech 2009 25 331 346 10.1016/j.nbt.2009.03.008
51. Role of water in aging of human butyrylcholinesterase inhibited by echothiophate: The crystal structure suggests two alternative mechanisms of aging. F Nachon OA Asojo GEO Borgstahl P Masson, Biochemistry 2005 44 1154 1162 10.1021/bi048238d 15667209